438 related articles for article (PubMed ID: 12421935)
1. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.
Gonzalez M; Quezada SA; Blazar BR; Panoskaltsis-Mortari A; Rudensky AY; Noelle RJ
J Immunol; 2002 Nov; 169(10):5581-9. PubMed ID: 12421935
[TBL] [Abstract][Full Text] [Related]
2. Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease.
Gendelman M; Hecht T; Logan B; Vodanovic-Jankovic S; Komorowski R; Drobyski WR
J Immunol; 2004 Mar; 172(5):3328-36. PubMed ID: 14978141
[TBL] [Abstract][Full Text] [Related]
3. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
Ito H; Kurtz J; Shaffer J; Sykes M
J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: sustained expansion of CD8+ T cells requires CD154 expression by Th cells in acute graft versus host disease.
Buhlmann JE; Gonzalez M; Ginther B; Panoskaltsis-Mortari A; Blazar BR; Greiner DL; Rossini AA; Flavell R; Noelle RJ
J Immunol; 1999 Apr; 162(8):4373-6. PubMed ID: 10201970
[TBL] [Abstract][Full Text] [Related]
5. Accelerated onset and increased severity of acute graft-versus-host disease following adoptive transfer of DR6-deficient T cells.
Liu J; Heuer JG; Na S; Galbreath E; Zhang T; Yang DD; Glasebrook A; Song HY
J Immunol; 2002 Oct; 169(7):3993-8. PubMed ID: 12244201
[TBL] [Abstract][Full Text] [Related]
6. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model.
Dey B; Yang YG; Preffer F; Shimizu A; Swenson K; Dombkowski D; Sykes M
Transplantation; 1999 Jul; 68(1):141-9. PubMed ID: 10428282
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
[TBL] [Abstract][Full Text] [Related]
8. Alloantigen affinity and CD4 help determine severity of graft-versus-host disease mediated by CD8 donor T cells.
Yu XZ; Albert MH; Anasetti C
J Immunol; 2006 Mar; 176(6):3383-90. PubMed ID: 16517706
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of graft-versus-host disease by double-negative regulatory T cells.
Young KJ; DuTemple B; Phillips MJ; Zhang L
J Immunol; 2003 Jul; 171(1):134-41. PubMed ID: 12816991
[TBL] [Abstract][Full Text] [Related]
10. Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells.
Lan F; Zeng D; Higuchi M; Huie P; Higgins JP; Strober S
J Immunol; 2001 Aug; 167(4):2087-96. PubMed ID: 11489992
[TBL] [Abstract][Full Text] [Related]
11. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.
Blazar BR; Lees CJ; Martin PJ; Noelle RJ; Kwon B; Murphy W; Taylor PA
J Immunol; 2000 Nov; 165(9):4901-9. PubMed ID: 11046015
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD3 epsilon F(ab')2 fragments inhibit T cell expansion in vivo during graft-versus-host disease or the primary immune response to nominal antigen.
Blazar BR; Jenkins MK; Taylor PA; White J; Panoskaltsis-Mortari A; Korngold R; Vallera DA
J Immunol; 1997 Dec; 159(12):5821-33. PubMed ID: 9550378
[TBL] [Abstract][Full Text] [Related]
13. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
Johnson BD; Becker EE; LaBelle JL; Truitt RL
J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
[TBL] [Abstract][Full Text] [Related]
14. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
Johnson BD; Becker EE; Truitt RL
Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958
[TBL] [Abstract][Full Text] [Related]
15. Generation of anergic and regulatory T cells following prolonged exposure to a harmless antigen.
Chen TC; Cobbold SP; Fairchild PJ; Waldmann H
J Immunol; 2004 May; 172(10):5900-7. PubMed ID: 15128770
[TBL] [Abstract][Full Text] [Related]
16. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
van Maurik A; Fazekas de St Groth B; Wood KJ; Jones ND
J Immunol; 2004 Feb; 172(4):2163-70. PubMed ID: 14764682
[TBL] [Abstract][Full Text] [Related]
17. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease.
Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG
J Immunol; 2005 Mar; 174(5):3051-8. PubMed ID: 15728519
[TBL] [Abstract][Full Text] [Related]
18. Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease.
Kato K; Cui S; Kuick R; Mineishi S; Hexner E; Ferrara JL; Emerson SG; Zhang Y
Biol Blood Marrow Transplant; 2010 Jun; 16(6):751-71. PubMed ID: 20116439
[TBL] [Abstract][Full Text] [Related]
19. Division rate and phenotypic differences discriminate alloreactive and nonalloreactive T cells transferred in lethally irradiated mice.
Maury S; Salomon B; Klatzmann D; Cohen JL
Blood; 2001 Nov; 98(10):3156-8. PubMed ID: 11698305
[TBL] [Abstract][Full Text] [Related]
20. Evolution of responding CD4+ and CD8+ T-cell repertoires during the development of graft-versus-host disease directed to minor histocompatibility antigens.
Friedman TM; Jones SC; Statton D; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2004 Apr; 10(4):224-35. PubMed ID: 15077221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
